Tiziana Life Sciences COO reports initial holdings
Tiziana Life Sciences Ltd executive Keeren Rameshchandra Shah, the Chief Operating & Financial Officer, filed an initial Form 3 reporting his beneficial ownership in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Tiziana Life Sciences Ltd executive Keeren Rameshchandra Shah, the Chief Operating & Financial Officer, filed an initial Form 3 reporting his beneficial ownership in the company. He holds 2,500 shares of common stock directly, along with multiple option awards over common shares.
These options cover various blocks of common stock at exercise prices of $0.50, $0.57, $0.82, $0.88 and $1.58 per share, with expiration dates ranging from 2030 to 2035. The filing lists these positions as existing holdings rather than new purchases or sales.
Insider Trade Summary
20 transactions reported
Mixed
20 txns
Insider
Shah Keeren Rameshchandra
Role
CHIEF OPERATING & FIN. OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | COMMON STOCK | -- | -- | -- |
Holdings After Transaction:
Options — 1,050,000 contracts (Direct);
COMMON STOCK — 2,500 shares (Direct)
Key Figures
Direct common stock holding: 2,500 shares
Option grant exercise price: $1.58 per share
Option grant exercise price: $0.82 per share
+3 more
6 metrics
Direct common stock holding
2,500 shares
Total shares of common stock held directly after reporting
Option grant exercise price
$1.58 per share
Options over 12,500 underlying common shares expiring 2035-09-04
Option grant exercise price
$0.82 per share
Options over 125,000 underlying common shares expiring 2034-10-03
Option grant exercise price
$0.50 per share
Options over 83,334 underlying common shares expiring 2034-03-13
Option grant exercise price
$0.57 per share
Options over 46,875 underlying common shares expiring 2033-03-14
Option grant exercise price
$0.88 per share
Options over 15,625 underlying common shares expiring 2030-05-06
Key Terms
Options, exercise price, expiration date, underlying security, +1 more
5 terms
Options financial
"Security title is "Options" with underlying common stock"
Options are contracts that give investors the right to buy or sell an asset at a specific price within a certain time frame. They function like a reservation or a ticket that allows for potential profit or protection against price changes, making them useful tools for managing investment risks or speculating on market movements.
exercise price financial
"Each option line includes an exercise price such as 0.5000 or 1.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"Option records list an expiration date running from 2030-05-06 to 2035-09-04"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"The underlying security title is reported as common stock for each option"
common stock financial
"Holdings include 2,500 shares of common stock held directly"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Tiziana Life Sciences (TLSA) Form 3 filing show for Keeren Shah?
The Form 3 shows that executive Keeren Rameshchandra Shah beneficially owns 2,500 TLSA common shares and multiple option grants. These options provide rights to buy common stock at fixed prices between $0.50 and $1.58 per share, expiring from 2030 through 2035.
What stock option grants are reported for Keeren Shah in the TLSA Form 3?
The Form 3 lists several option positions over TLSA common stock with exercise prices of $0.50, $0.57, $0.82, $0.88 and $1.58. Each grant has a specified expiration date between 2030 and 2035, indicating long-dated incentives tied to the company’s share price.
Are there any buy or sell transactions in the Tiziana Life Sciences (TLSA) Form 3?
The filing presents Shah’s holdings as of the reporting date and does not show explicit buy or sell transactions. Entries are categorized as holdings, meaning the document primarily establishes his existing ownership in TLSA shares and options rather than recent trades.
What are the expiration dates for Keeren Shah’s TLSA stock options?
Shah’s reported TLSA stock options have expiration dates ranging from 2030-05-06 to 2035-09-04. These long-term expirations indicate multi-year incentive arrangements, allowing potential future exercises if Tiziana Life Sciences’ share price exceeds the respective exercise prices.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates